Fig. 2From: Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver diseaseMetabolomics profile of hepatic tissue assessing the impact of NMN therapy in a model of ethanol toxicity. a NMN treatment significantly alters metabolites of nicotinamide metabolism. b TCA cycle metabolites are moderately altered due to NMN supplementation (mean +/− SEM) (n ≥ 4) (*p < 0.05, **p < 0.01, ***p < 0.001)Back to article page